Perspectives on the 2018 HHS Drug Pricing Guidance

This is the agenda for the Brazda Breakfast: Reporting on the Future of Health Care titled "Perspectives on 2018 HHS Drug Pricing Guidance" held on May 15, 2018, in Washington D.C.

9:00 a.m. – 9:05 a.m. Welcome and Introductions

William Pierce, MPIA, senior director, APCO Worldwide
Mary Ella Payne, R.N., MSPH, acting president and chief executive officer, Alliance for Health Policy

9:05 a.m. – 9:35 a.m. Perspectives from the Administration

Scott Gottlieb, M.D., Commissioner of Food and Drugs, U.S. Food and Drug Administration

9:40 a.m. – 10:30 a.m. Perspectives from Stakeholders

Lauren Aronson, executive director, Campaign for Sustainable Drug Pricing
Kristin Bass, MBA, senior vice president, Policy and Federal Affairs, Pharmaceutical Care Management Association
Justine Handelman, senior vice president, Office of Policy and Representation, Blue Cross Blue Shield Association
Lori Reilly, J.D., executive vice president, Policy, Research, and Membership, Pharmaceutical Research and Manufacturers of America

Nov18

Past Series

Voices from the Frontlines

Voices from the Frontlines brought together leading voices in health care and public health for an afternoon of conversation and inspiration. For the first time, these exceptional individuals, who have been paramount in the effort to combat COVID-19 over the past 18 months, were together on one virtual stage. This event allowed our community the opportunity to directly engage with those on the frontlines of this pandemic, and to hear their personal stories of perseverance in the face of great challenge.

Learn More

Share